Download PDF
1 / Pages

Other users also viewed these articles

Sofosbuvir-based regimens for HCV in stage 4¿stage 5 chronic kidney disease. A systematic review with meta-analysis Fabrizio Fabrizi; Roberta Cerutti; Vivek Dixit; Ezequiel Ridruejo;
Nefrologia (English Version). 2021;41:578-89
The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis Fabrizio Fabrizi; Roberta Cerutti; Vivek Dixit; Piergiorgio Messa;
Nefrologia (English Version). 2020;40:299-310
Information and consensus document for the detection and management of chronic kidney disease Rafael García-Maset; Jordi Bover; Julián Segura de la Morena; Marian Goicoechea Diezhandino; Jesús Cebollada del Hoyo; Javier Escalada San Martin; Lorenzo Fácila Rubio; Javier Gamarra Ortiz; Jose A. García-Donaire; Lisardo García-Matarín; Sílvia Gràcia Garcia; María Isabel Gutiérrez Pérez; Julio Hernández Moreno; Pilar Mazón Ramos; Rosario Montañés Bermudez; Manuel Muñoz Torres; Pedro de Pablos-Velasco; Manuel Pérez-Maraver; Carmen Suárez Fernández; Salvador Tranche Iparraguirre; José Luis Górriz;
Nefrologia (English Version). 2022;42:233-64